1-3 of 3
Kaitlyn Shank, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cooperative Epigenetic Remodeling By TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity

Hiroyoshi Kunimoto, MD PhD, Cem Meydan, PhD, Abbas Nazir, BS, Kaitlyn Shank, BS, Rebecca Maher, BA, Franck Rapaport, PhD, Elodie Pronier, PhD, Ari Melnick, MD, Ross L. Levine, MD, Alan H. Shih, MD PhD
Journal: Blood
Blood (2016) 128 (22): 433.
https://doi.org/10.1182/blood.V128.22.433.433
Published: 2016
Journal Articles

Dose-Dependent Role of the Cohesin Complex in Normal and Malignant Hematopoiesis

Aaron D. Viny, MD MS, Christopher J. Ott, PhD, Barbara Spitzer, MD, Martin A Rivas, PhD, Cem Meydan, Efthymia Papalexi, Dana Yelin, MD, Kaitlyn Shank, BS, Jaime Reyes, April Chiu, MD, Swapna Thota, MD, Jaroslaw P Maciejewski, MD PhD FACP, Ari Melnick, MD, James E. Bradner, MD, Ross L. Levine, MD
Journal: Blood
Blood (2015) 126 (23): 435.
https://doi.org/10.1182/blood.V126.23.435.435
Published: 2015
Journal Articles

Lysine-Specific Histone Demethylase, LSD1, (KDM1A) As a Novel Therapeutic Target in Myeloproliferative Neoplasms

Maria Kleppe, PhD, Kaitlyn Shank, BS, Papalexi Efthymia, BS, Hugh Riehnhoff, MD, Ross L. Levine, MD
Journal: Blood
Blood (2015) 126 (23): 601.
https://doi.org/10.1182/blood.V126.23.601.601
Published: 2015